Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 402.6 Million USD | 16.09% |
| 2022 | 346.8 Million USD | 14.38% |
| 2021 | 303.2 Million USD | 96.5% |
| 2020 | 154.3 Million USD | 52.77% |
| 2019 | 101 Million USD | 41.43% |
| 2018 | 71.41 Million USD | 111.33% |
| 2017 | 33.79 Million USD | -4.85% |
| 2016 | 35.51 Million USD | 195.36% |
| 2015 | 12.02 Million USD | -8.21% |
| 2014 | 13.09 Million USD | 38.41% |
| 2013 | 9.46 Million USD | -36.34% |
| 2012 | 14.86 Million USD | 25.59% |
| 2011 | 11.83 Million USD | 3.57% |
| 2010 | 11.43 Million USD | 13.33% |
| 2009 | 10.08 Million USD | -40.21% |
| 2008 | 16.87 Million USD | 111.14% |
| 2007 | 7.99 Million USD | 135.69% |
| 2006 | 3.39 Million USD | 292.36% |
| 2005 | 864 Thousand USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 430.9 Million USD | 0.07% |
| 2024 Q1 | 430.6 Million USD | 6.95% |
| 2023 Q4 | 402.6 Million USD | -2.0% |
| 2023 Q1 | 386.1 Million USD | 11.33% |
| 2023 Q2 | 411.3 Million USD | 6.53% |
| 2023 FY | 402.6 Million USD | 16.09% |
| 2023 Q3 | 410.8 Million USD | -0.12% |
| 2022 Q4 | 346.8 Million USD | 5.86% |
| 2022 FY | 346.8 Million USD | 14.38% |
| 2022 Q3 | 327.6 Million USD | 2.25% |
| 2022 Q1 | 314.8 Million USD | 3.83% |
| 2022 Q2 | 320.4 Million USD | 1.78% |
| 2021 Q4 | 303.2 Million USD | 17.07% |
| 2021 Q2 | 197.8 Million USD | 16.28% |
| 2021 Q1 | 170.1 Million USD | 10.24% |
| 2021 FY | 303.2 Million USD | 96.5% |
| 2021 Q3 | 259 Million USD | 30.94% |
| 2020 Q1 | 95.7 Million USD | -5.25% |
| 2020 Q3 | 124.9 Million USD | 20.44% |
| 2020 Q4 | 154.3 Million USD | 23.54% |
| 2020 Q2 | 103.7 Million USD | 8.36% |
| 2020 FY | 154.3 Million USD | 52.77% |
| 2019 Q4 | 101 Million USD | 11.96% |
| 2019 Q2 | 85.1 Million USD | 15.29% |
| 2019 Q3 | 90.2 Million USD | 5.99% |
| 2019 Q1 | 73.82 Million USD | 3.37% |
| 2019 FY | 101 Million USD | 41.43% |
| 2018 FY | 71.41 Million USD | 111.33% |
| 2018 Q4 | 71.41 Million USD | 23.02% |
| 2018 Q1 | 26.33 Million USD | -22.07% |
| 2018 Q2 | 40.8 Million USD | 54.96% |
| 2018 Q3 | 58.05 Million USD | 42.25% |
| 2017 FY | 33.79 Million USD | -4.85% |
| 2017 Q4 | 33.79 Million USD | -3.6% |
| 2017 Q3 | 35.05 Million USD | 3.23% |
| 2017 Q2 | 33.95 Million USD | -1.1% |
| 2017 Q1 | 34.33 Million USD | -3.33% |
| 2016 Q2 | 24.48 Million USD | 74.6% |
| 2016 Q4 | 35.51 Million USD | 8.73% |
| 2016 FY | 35.51 Million USD | 195.36% |
| 2016 Q1 | 14.02 Million USD | 16.63% |
| 2016 Q3 | 32.66 Million USD | 33.39% |
| 2015 Q4 | 12.02 Million USD | -7.64% |
| 2015 Q2 | 23.43 Million USD | 16.8% |
| 2015 FY | 12.02 Million USD | -8.21% |
| 2015 Q3 | 13.01 Million USD | -44.45% |
| 2015 Q1 | 20.06 Million USD | 53.18% |
| 2014 Q4 | 13.09 Million USD | 35.57% |
| 2014 FY | 13.09 Million USD | 38.41% |
| 2014 Q1 | 10.44 Million USD | 10.41% |
| 2014 Q2 | 8.76 Million USD | -16.12% |
| 2014 Q3 | 9.66 Million USD | 10.23% |
| 2013 Q1 | 9.19 Million USD | -38.12% |
| 2013 Q4 | 9.46 Million USD | 75.42% |
| 2013 Q3 | 5.39 Million USD | -9.77% |
| 2013 Q2 | 5.97 Million USD | -35.0% |
| 2013 FY | 9.46 Million USD | -36.34% |
| 2012 FY | 14.86 Million USD | 25.59% |
| 2012 Q1 | 14.7 Million USD | 24.2% |
| 2012 Q4 | 14.86 Million USD | -1.47% |
| 2012 Q3 | 15.08 Million USD | -8.14% |
| 2012 Q2 | 16.42 Million USD | 11.72% |
| 2011 Q4 | 11.83 Million USD | -9.79% |
| 2011 FY | 11.83 Million USD | 3.57% |
| 2011 Q3 | 13.12 Million USD | -17.76% |
| 2011 Q2 | 15.95 Million USD | 30.81% |
| 2011 Q1 | 12.19 Million USD | 6.73% |
| 2010 FY | 11.43 Million USD | 13.33% |
| 2010 Q1 | 6.6 Million USD | -34.56% |
| 2010 Q2 | 10.23 Million USD | 55.02% |
| 2010 Q3 | 12.9 Million USD | 26.18% |
| 2010 Q4 | 11.43 Million USD | -11.46% |
| 2009 Q1 | 15.14 Million USD | -10.21% |
| 2009 Q4 | 10.08 Million USD | 9.93% |
| 2009 Q3 | 9.17 Million USD | -11.86% |
| 2009 Q2 | 10.4 Million USD | -31.28% |
| 2009 FY | 10.08 Million USD | -40.21% |
| 2008 Q4 | 16.87 Million USD | 2.45% |
| 2008 Q2 | 13.33 Million USD | 77.67% |
| 2008 FY | 16.87 Million USD | 111.14% |
| 2008 Q1 | 7.5 Million USD | -6.06% |
| 2008 Q3 | 16.46 Million USD | 23.48% |
| 2007 Q1 | 4.25 Million USD | 25.55% |
| 2007 Q2 | 4.12 Million USD | -2.98% |
| 2007 Q3 | 4.57 Million USD | 10.73% |
| 2007 Q4 | 7.99 Million USD | 74.76% |
| 2007 FY | 7.99 Million USD | 135.69% |
| 2006 Q4 | 3.39 Million USD | 51.0% |
| 2006 Q3 | 2.24 Million USD | 0.0% |
| 2006 FY | 3.39 Million USD | 292.36% |
| 2005 FY | 864 Thousand USD | 0.0% |
| 2005 Q4 | 864 Thousand USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -12063.142% |
| BrainsWay Ltd. | 3.71 Million USD | -10731.316% |
| Cerus Corporation | 39.86 Million USD | -909.832% |
| Envoy Medical, Inc. | 1.4 Million USD | -28575.214% |
| electroCore, Inc. | 2.16 Million USD | -18538.889% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -87996.28% |
| IceCure Medical Ltd | 2.27 Million USD | -17596.703% |
| Inogen, Inc. | 21.84 Million USD | -1743.407% |
| OrthoPediatrics Corp. | 105.85 Million USD | -280.346% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -144720.144% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -40259999900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -3192.174% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -23216.341% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -257283.966% |
| Orthofix Medical Inc. | 222.16 Million USD | -81.216% |
| PAVmed Inc | 1.01 Million USD | -39487.06% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -1916.933% |
| RxSight, Inc. | 17.42 Million USD | -2211.004% |
| Sight Sciences, Inc. | 7.84 Million USD | -5029.316% |
| SI-BONE, Inc. | 20.24 Million USD | -1888.246% |
| TELA Bio, Inc. | 13.16 Million USD | -2958.806% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -1276.646% |
| Vivos Therapeutics, Inc. | 1.00 USD | -40259999900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -9310.94% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -174943.478% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -16988.285% |
| CVRx, Inc. | 10.98 Million USD | -3565.665% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -103110.656% |
| Bioventus Inc. | 91.33 Million USD | -340.805% |
| Venus Concept Inc. | 28.67 Million USD | -1303.962% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -15719.253% |
| LivaNova PLC | 147.88 Million USD | -172.235% |
| 908 Devices Inc. | 14.93 Million USD | -2595.14% |
| Alphatec Holdings, Inc. | 136.84 Million USD | -194.208% |
| Nemaura Medical Inc. | 1.75 Million USD | -22842.106% |
| NeuroPace, Inc. | 11.21 Million USD | -3490.155% |
| LENSAR, Inc. | 15.68 Million USD | -2466.129% |
| Apyx Medical Corporation | 9.92 Million USD | -3957.241% |
| Cutera, Inc. | 72.1 Million USD | -458.383% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -14961.728% |
| BioSig Technologies, Inc. | -103 Thousand USD | 390973.786% |
| Anika Therapeutics, Inc. | 46.38 Million USD | -767.934% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -4989.116% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | -3.335% |
| Axonics, Inc. | 79.94 Million USD | -403.628% |
| Outset Medical, Inc. | 49.21 Million USD | -718.043% |
| IRIDEX Corporation | 9.9 Million USD | -3964.204% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -912.677% |
| IRadimed Corporation | 12.82 Million USD | -3040.113% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -53153.968% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -152107.692% |
| Telesis Bio, Inc. | 4.02 Million USD | -9902.484% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -8643.96% |
| Varex Imaging Corporation | 277.5 Million USD | -45.081% |
| Quipt Home Medical Corp. | 18.32 Million USD | -2096.909% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -2304.587% |
| Dynatronics Corporation | 5.59 Million USD | -7097.03% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -10661.828% |
| Semler Scientific, Inc. | 445 Thousand USD | -90371.91% |
| InMode Ltd. | 45.09 Million USD | -792.782% |
| Bruker Corporation | 968.3 Million USD | 58.422% |
| Cytosorbents Corporation | 3.68 Million USD | -10839.834% |
| DexCom, Inc. | 559.6 Million USD | 28.056% |
| Align Technology, Inc. | 296.9 Million USD | -35.6% |
| Viveve Medical, Inc. | 1.47 Million USD | -27250.543% |
| ZimVie Inc. | 79.6 Million USD | -405.779% |
| Movano Inc. | 1.51 Million USD | -26509.385% |
| Cytek Biosciences, Inc. | 60.87 Million USD | -561.334% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -257283.966% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | -154.912% |
| Profound Medical Corp. | 6.95 Million USD | -5690.105% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -2613.121% |
| iCAD, Inc. | 917 Thousand USD | -43804.035% |
| Nuwellis, Inc. | 1.99 Million USD | -20060.24% |
| Biotricity, Inc. | 1.87 Million USD | -21321.708% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -2781.271% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -19016.809% |
| PAVmed Inc. | 1.01 Million USD | -39487.06% |
| BIOLASE, Inc. | 11.43 Million USD | -3421.385% |
| Beyond Air, Inc. | 2.12 Million USD | -18828.068% |
| FONAR Corporation | 2.71 Million USD | -14726.321% |
| AxoGen, Inc. | 23.02 Million USD | -1648.914% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -1687.189% |
| Inari Medical, Inc. | 42.9 Million USD | -838.462% |
| UFP Technologies, Inc. | 70.19 Million USD | -473.578% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -63888.15% |
| Tenon Medical, Inc. | 554 Thousand USD | -72571.48% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -24084.175% |
| AdaptHealth Corp. | 113.64 Million USD | -254.27% |
| Sintx Technologies, Inc. | 888 Thousand USD | -45237.838% |
| NanoVibronix, Inc. | 2.73 Million USD | -14636.457% |
| Quanterix Corporation | 22.36 Million USD | -1700.134% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -2611.659% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | -610.354% |
| TransMedics Group, Inc. | 44.23 Million USD | -810.139% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -7021.882% |
| NeuroMetrix, Inc. | 1.55 Million USD | -25717.159% |
| Hyperfine, Inc. | 6.58 Million USD | -6016.682% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | -403.634% |
| Biomerica, Inc. | 2.37 Million USD | -16844.444% |
| Bone Biologics Corporation | -328.84 Thousand USD | 122528.872% |
| AVITA Medical, Inc. | 3.12 Million USD | -12798.009% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -1247.57% |